简 体
繁 體
English
Vision & Mission
Based upon our Prodrug Platform and Functional Group Switch (FGS) Platform, we focus on developing a series of new CNS drugs that exhibit superior advantages leading to improved patients' compliance/convenience and/or lowered toxicity profile during drug treatment. We strive to become a leading China-based R&D company with its primary focus on the China market and via collaboration with other companies for foreign markets.
Copyright 2015 XW Laboratories Inc. All rights reserved.